Cabozantinib S-malate
Specifications
1140909-48-3CAS Number
691-711-0EC Number
1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acidIUPAC Name
C32H30FN3O10Chemical Formula
635.6 g/molMolecular Weight
Cabozantinib S-malate; 1140909-48-3; Cabozantinib malate; cabozantinib (S)-malate; Cabometyx; XL184; DR7ST46X58; CHEBI:72319; DTXSID60915949; RefChem:1080604; DTXCID501510465; Cabozantinib malate (XL184); Cabozantinib (S-malate); Cabozantinib L-Malate Salt; MFCD20923480; Cabozantinib s-malate [USAN]; C32H30FN3O10; 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acid; N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate; Cabometyx (TN); Cometriq (TN); Cabozantinib malate (JAN); Cabozantinib s-malate (USAN); CABOZANTINIB MALATE [JAN]; cabozantinib L-malate; UNII-DR7ST46X58; XL184 (S-malate);BMS-907351 (S-malate); RESNIBEN; XL-184 malate; Cabozantinib S-malate?; Cabozantinib S-Malate salt; XL184(Cabozantinib malate); MLS006010951; orb1226924; orb1307421; CHEMBL2103868; SCHEMBL29350740; SCHEMBL29881226; HFCFMRYTXDINDK-WNQIDUERSA-N; GLXC-10543; EX-A2819; EBC-17171; AKOS025401945; CABOZANTINIB S-MALATE [WHO-DD]; CCG-270301; CS-0201; FC64967; AC-27471; AS-75255; HY-12044; SMR004702755; SY105860; CABOZANTINIB S-MALATE [ORANGE BOOK]; SW218093-2; D10095; F861544; Q27139901; (2S)-2-Hydroxybutanedioic acid--N~1~-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (1/1); (2S)-2-hydroxybutanedioic acid; N'1-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; 1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)- mono((2S)-2-hydroxybutanedioate); Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7- dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1- cyclopropanedicarboxamide; cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide, (S) malate salt; inverted exclamation mark N-[4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl]-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-Hydroxysuccinate; N-(4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE MONO((2S)-2-HYDROXYBUTANEDIOATE); N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate; N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (2S)-2-hydroxybutanedioate; N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acidSynonyms
Products Containing Cabozantinib S-malate
카보메틱스정20밀리그램(카보잔티닙)카보메틱스정40밀리그램(카보잔티닙)카보메틱스정60밀리그램(카보잔티닙)CABOMETYX 60 mg, comprimé pelliculéCABOMETYX 40 mg, comprimé pelliculéCABOMETYX 20 mg, comprimé pelliculéCabozantinib Malate; CAS:1140909-48-3Cabozantinib MalateCabozantinib MalateCabometyxCabozantinib Malate1140909-48-3
Page 1 of 2
Companies Selling Cabozantinib S-malate
JM
Jiangsu Magic Biotechnology Co., LtdChinaHD
Hangzhou Dingyan Chem Co., LtdChinaSQ
SICHUAN QINGMU PHARMACEUTICAL CO.,LTD.ChinaSD
SHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTDChinaWH
Wuxi Hexia Chemical CompanyChina입센
입센코리아(주)Republic of KoreaBS
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.ChinaV(
VuRoyal (SuQian) Pharmaceutical Company LLCChina